4-hydroxymephenytoin has been researched along with mephenytoin in 33 studies
Studies (4-hydroxymephenytoin) | Trials (4-hydroxymephenytoin) | Recent Studies (post-2010) (4-hydroxymephenytoin) | Studies (mephenytoin) | Trials (mephenytoin) | Recent Studies (post-2010) (mephenytoin) |
---|---|---|---|---|---|
36 | 5 | 0 | 580 | 35 | 32 |
Protein | Taxonomy | 4-hydroxymephenytoin (IC50) | mephenytoin (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 1.185 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (12.12) | 18.7374 |
1990's | 19 (57.58) | 18.2507 |
2000's | 10 (30.30) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiba, K; Ishizaki, T; Jang, IJ; Kusaka, M; Shin, JG; Shin, SG; Sohn, DR | 1 |
Horsmans, Y; Lannes, D; Larrey, D; Letteron, P; Loeper, J; Pessayre, D; Tinel, M | 1 |
Anthony, LB; Wilkinson, GR; Wood, AJ; Zhou, HH | 1 |
Dulac, H; Jacqz, E; Mathieu, H | 1 |
Branch, RA; Küpfer, A | 1 |
Aslanian, WS; Branch, RA; McAllister, CB; Wedlund, PJ; Wilkinson, GR | 1 |
Branch, RA; Küpfer, A; Patwardhan, R; Preisig, R; Schenker, S; Ward, S | 1 |
Huang, SL; Xie, HG; Zhou, HH | 1 |
Flockhart, DA; Hadidi, HF; Idle, JR; Irshaid, YM; Woosley, RL | 1 |
Caslavska, J; Desiderio, C; Hufschmid, E; Theurillat, R; Thormann, W; Wolfisberg, H | 1 |
Cheng, YS; Ding, DY; Ruan, ZR | 1 |
Desiderio, C; Fanali, S; Küpfer, A; Thormann, W | 1 |
Chiba, K; Ishizaki, T; Kobayashi, K; Manabe, K; Takayama, Y; Tani, M | 1 |
Kunze, KL; Rettie, AE; Storch, E; Trager, WF; Wienkers, LC; Wurden, CJ | 1 |
Wedlund, PJ; Wilkinson, GR | 1 |
Chiba, K; Hakusui, H; Ishizaki, T; Kaneko, S; Kato, K; Ohkubo, T; Otani, K; Sudo, K; Sugawara, K; Tanaka, M | 1 |
Bajpai, M; Levy, RH; Roskos, LK; Shen, DD | 1 |
Hakusui, H; Ishizaki, T; Kaneko, S; Ohkubo, T; Otani, K; Ryokawa, Y; Sugawara, K; Suzuki, A; Tanaka, M; Yamamori, S | 1 |
Feng, HJ; Huang, SL; Wang, W; Zhou, HH | 1 |
Adedoyin, A; Arns, PA; Branch, RA; Richards, WO; Wilkinson, GR | 1 |
Huang, SL; Jiang, CH; Liu, JH; Wu, JX; Xie, HG; Xu, ZH; Zhou, HH | 1 |
Bochner, F; Coller, JK; Somogyi, AA | 1 |
Baker, GB; Coutts, RT; Salsali, M | 1 |
Feldman, AM; Frye, CS; Frye, RF; Schneider, VM | 1 |
Kalhorn, TF; Lakehal, F; Levy, RH; Wurden, CJ | 1 |
Chen, XP; Huang, SL; Huang, Z; Ou-Yang, DS; Tan, ZR; Zhou, HH | 1 |
Bell, AR; Crewe, HK; Graham, MJ; Lennard, MS; Moorcraft, CL; Walker, L; Whittaker, EF | 1 |
Kharasch, ED; Kunze, KL; Levy, RH; Trager, WF; Yao, C | 1 |
Ashton, M; Jansson, B; Simonsson, US | 1 |
Abd El-Aty, AM; An, W; Chen, GL; Li, Q; Li, Z; Liu, J; Tang, ZR; Wang, D; Wang, LS; Wu, J; Zhou, G; Zhou, HH; Zhu, B | 1 |
Fuhr, U; Harlfinger, S; Kasel, D; Klaassen, T | 1 |
Elsherbiny, D; Jansson, B; Simonsson, US | 1 |
Branch, RA; Chaves-Gnecco, D; Frye, RF; Matzke, GR; Rabinovitz, M; Shaikh, OS; Zgheib, NK | 1 |
5 trial(s) available for 4-hydroxymephenytoin and mephenytoin
Article | Year |
---|---|
S-mephenytoin hydroxylation phenotypes in a Jordanian population.
Topics: Adolescent; Adult; Anticonvulsants; Debrisoquin; Female; Gene Frequency; Humans; Hydroxylation; Jordan; Male; Mephenytoin; Metabolism; Middle Aged; Phenotype; Prevalence; Sympatholytics | 1995 |
Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures.
Topics: Acetylation; Adult; Biotransformation; Caffeine; Chromatography, High Pressure Liquid; Dextromethorphan; Electrophoresis, Polyacrylamide Gel; Humans; Hydroxylation; Mephenytoin; Middle Aged; Phenotype; Polymorphism, Genetic | 1994 |
Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.
Topics: Adult; Aged; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Liver Diseases; Male; Mephenytoin; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Stereoisomerism; Sympatholytics | 1998 |
The influence of St John's Wort on CYP2C19 activity with respect to genotype.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Genotype; Humans; Hypericum; Male; Mephenytoin; Mixed Function Oxygenases; Plant Extracts; Polymorphism, Genetic | 2004 |
Liver disease selectively modulates cytochrome P450--mediated metabolism.
Topics: Administration, Oral; Adult; Anticonvulsants; Antihypertensive Agents; Caffeine; Case-Control Studies; Chlorzoxazone; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Debrisoquin; Humans; Isoenzymes; Liver Diseases; Male; Mephenytoin; Middle Aged; Muscle Relaxants, Central; Phosphodiesterase Inhibitors; Severity of Illness Index; Theophylline | 2006 |
28 other study(ies) available for 4-hydroxymephenytoin and mephenytoin
Article | Year |
---|---|
Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.
Topics: Adult; Asian People; Creatinine; Diazepam; Female; Humans; Hydroxylation; Korea; Male; Mephenytoin; Mixed Function Oxygenases; Nordazepam; Phenotype; Polymorphism, Genetic | 1992 |
Nilutamide inhibits mephenytoin 4-hydroxylation in untreated male rats and in human liver microsomes.
Topics: Androgen Antagonists; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Female; Ferricyanides; Humans; Hydroxylation; Imidazoles; Imidazolidines; Male; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred Strains; Troleandomycin | 1991 |
Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin.
Topics: Adult; Female; Humans; Hydroxylation; Male; Mephenytoin; Middle Aged; Phenotype; Rifampin | 1990 |
Phenotyping polymorphic drug metabolism in the French Caucasian population.
Topics: Adult; Dextromethorphan; Female; France; Humans; Hydantoins; Levorphanol; Male; Mephenytoin; Middle Aged; Phenotype; Polymorphism, Genetic; White People | 1988 |
Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Humans; Hydantoins; Hydroxylation; Mephenytoin; Mephobarbital; Phenotype; Stereoisomerism | 1985 |
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Debrisoquin; Female; Humans; Hydantoins; Hydroxylation; Male; Mephenytoin; Middle Aged; Phenotype; Polymorphism, Genetic; Tennessee; White People | 1984 |
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
Topics: Adolescent; Adult; Anticonvulsants; Half-Life; Humans; Hydantoins; Male; Mephenytoin; Stereoisomerism; Time Factors | 1984 |
High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans.
Topics: Aryl Hydrocarbon Hydroxylases; Biomarkers; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Humans; Liver; Mephenytoin; Mixed Function Oxygenases; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1995 |
[Determination of mephenytoin and 4'-hydroxymephenytoin in urine by high performance liquid chromatography].
Topics: Chromatography, High Pressure Liquid; Humans; Mephenytoin | 1994 |
Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in man.
Topics: Buffers; Capillary Action; Chromatography; Cyclodextrins; Humans; Hydroxylation; Kinetics; Mephenytoin; Micelles; Phenytoin; Stereoisomerism | 1994 |
Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes.
Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Humans; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Polymorphism, Genetic | 1993 |
Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
Topics: Aryl Hydrocarbon Hydroxylases; Biomarkers; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluconazole; Humans; Hydroxylation; Kinetics; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Theophylline; Tranylcypromine; Warfarin | 1996 |
In vivo and in vitro measurement of CYP2C19 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Mephenytoin; Mixed Function Oxygenases; Omeprazole; Phenotype; Polymorphism, Genetic; Stereoisomerism; Substrate Specificity | 1996 |
Simple and selective assay of 4-hydroxymephenytoin in human urine using solid-phase extraction and high-performance liquid chromatography with electrochemical detection and its preliminary application to phenotyping test.
Topics: Adult; Animals; Anticonvulsants; Calibration; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Indicators and Reagents; Male; Mephenytoin; Phenotype; Rats; Solutions | 1996 |
Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.
Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Kinetics; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Phenytoin; Stereoisomerism; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 1996 |
Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Half-Life; Humans; Japan; Male; Mephenytoin; Metabolic Clearance Rate; Mixed Function Oxygenases; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 1997 |
The induction effect of rifampicin on activity of mephenytoin 4'-hydroxylase related to M1 mutation of CYP2C19 and gene dose.
Topics: Adult; Antibiotics, Antitubercular; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Enzyme Induction; Humans; Hydroxylation; Male; Mephenytoin; Mixed Function Oxygenases; Mutation; Rifampin; Stereoisomerism | 1998 |
No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Oxidation-Reduction; Propranolol | 1997 |
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
Topics: Adult; Aged; Antibodies, Monoclonal; Anticonvulsants; Antimetabolites; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Folic Acid Antagonists; Genotype; Humans; In Vitro Techniques; Isoenzymes; Male; Mephenytoin; Microsomes, Liver; Middle Aged; Oxidation-Reduction; Proguanil; Triazines | 1999 |
Analysis of dextrorphan, a metabolite of dextromethorphan, using gas chromatography with electron-capture detection.
Topics: Benzoates; Chromatography, Gas; Dextrorphan; Drug Stability; Humans; In Vitro Techniques; Mephenytoin; Microsomes, Liver; Oxidation-Reduction; Solubility | 1999 |
Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure.
Topics: Adult; Aged; Biomarkers; Cytochrome P-450 Enzyme System; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Genetic Markers; Genotype; Heart Failure; Humans; Interleukin-6; Male; Mephenytoin; Middle Aged; Mutation; Phenotype; Polymorphism, Genetic; Prevalence; Statistics as Topic; Tumor Necrosis Factor-alpha | 2002 |
Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.
Topics: Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Chlorophyll; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Liver; Mephenytoin; Microsomes; Mixed Function Oxygenases; Oxcarbazepine; Phenytoin; Recombinant Proteins | 2002 |
Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Caffeine; China; Chlorzoxazone; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Isoenzymes; Male; Mephenytoin; Metoprolol; Midazolam; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Phenotype; Reference Values; Theophylline | 2003 |
mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
Topics: Algorithms; Animals; Cytochrome P-450 Enzyme System; Dextromethorphan; Dogs; Female; Humans; Isoenzymes; Kinetics; Liver; Male; Mephenytoin; Microsomes, Liver; Omeprazole; Protein Biosynthesis; RNA, Messenger; Warfarin | 2003 |
Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19.
Topics: Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fluvoxamine; Humans; In Vitro Techniques; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Time Factors | 2003 |
Simultaneous enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma by liquid chromatography.
Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Humans; Mephenytoin; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stereoisomerism | 2003 |
Quantification of mephenytoin and its metabolites 4'-hydroxymephenytoin and nirvanol in human urine using a simple sample processing method.
Topics: Aryl Hydrocarbon Hydroxylases; Calibration; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Humans; Male; Mass Spectrometry; Mephenytoin; Mixed Function Oxygenases; Molecular Structure; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry.
Topics: Chromatography, Liquid; Humans; Mass Spectrometry; Mephenytoin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2006 |